The company, Marion Biotech, bought the ingredient – propylene glycol (PG) – from trader Maya Chemtech India, as reported by Reuters. But Maya did not have a licence to sell pharmaceutical-grade materials and “dealt in industrial-grade only,” according to a source at the firm with knowledge of the Marion investigation.
